Abbott is teaming up with AtaCor Medical to develop a next-generation implantable cardioverter defibrillator (ICD) designed ...
Cardiac device therapy has significantly evolved since the introduction of the first implantable pacemaker and the subsequent ...
Please provide your email address to receive an email when new articles are posted on . Bystander use of an automated external defibrillator after cardiac arrest improves survival odds at 30 days.
Registry data suggest that one third of the patients who would benefit most are not receiving timely defibrillation. In the U.S., in-hospital cardiac arrest occurs about twice as often as ...
Since 1990, emergency personnel in Rochester, Minnesota, and surrounding communities have provided early defibrillation to victims of out-of-hospital cardiac arrest. Researchers followed 200 ...
In cardiac arrest, the speed and type of treatment can literally mean life or death in the immediate term, but can also affect health outcomes after successful resuscitation. During out-of-hospital ...
A new device called a subcutaneous implantable cardioverter defibrillator (S-ICD) prevents sudden cardiac death with an electric shock. A conductor wire is implanted just under the skin, rather than ...
Medtronic this week launched its OmniaSecure defibrillation lead in the U.S., describing it as the world's smallest.
Expert guidelines advocate defibrillation within 2 minutes after an in-hospital cardiac arrest caused by ventricular arrhythmia. However, empirical data on the prevalence of delayed defibrillation in ...